Home › Companies › Ligand Pharmaceuticals Incorporated
How asset managers voted at Ligand Pharmaceuticals Incorporated’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Ligand Pharmaceuticals Incorporated | 12 | 395 |
| 2024-2025 | Ligand Pharmaceuticals Incorporated | 11 | 328 |
| 2023-2024 | LIGAND PHARMACEUTICALS INC. | 11 | 297 |
Earlier seasons list this company under the name LIGAND PHARMACEUTICALS INC., as its holders filed it.
Explore Ligand Pharmaceuticals Incorporated in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 16, 2026.